Video

Potential Molecular Markers in Liver Cancer

Anuradha S. Budhu, PhD, discusses using molecular features as predictive markers in liver cancer.

Anuradha S. Budhu, PhD, senior associate scientist, Laboratory of Human Carcinogenesis, program manager, Liver Cancer Program, Center for Cancer Research, National Cancer Institute, discusses using molecular features as predictive markers in liver cancer.

Genes are an important molecular feature that can shed light on individual biology, says Budhu. As such, investigators compare normally expressed genes with dysregulated or overexpressed genes to gain insight on cancer biology.

Other potential markers include microRNAs and downstream affecters of gene signaling such as metabolites and proteins, says Budhu.

By measuring the abundance of these features, investigators are aiming to understand tumor biology. These markers may help to identify liver cancer in patients, predict the aggressiveness of the disease, and determine which patients will benefit the most from treatment.

Related Videos
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss ongoing research in gastrointestinal cancers.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss research building upon approved combinations in unresectable hepatocellular carcinoma.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on trastuzumab deruxtecan–based regimens in advanced HER2-positive GI cancers.
Yair Lotan, MD, UT Southwestern Medical Center
Alan Tan, MD, Vanderbilt-Ingram Cancer Center
Alex Herrera, MD
Roy S. Herbst, MD, PhD
Sheldon M. Feldman, MD
Laura J. Chambers, DO
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on tremelimumab/durvalumab vs atezolizumab/bevacizumab in unresectable HCC.